Dual Inhibitor Overcomes Gemcitabine Resistance in TNBC
In an era where triple-negative breast cancer (TNBC) continues to challenge oncologists due to its aggressive nature and resistance to ...
In an era where triple-negative breast cancer (TNBC) continues to challenge oncologists due to its aggressive nature and resistance to ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine